These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 1992343

  • 21. Hydrolysis of phosphatidylcholine couples Ras to activation of Raf protein kinase during mitogenic signal transduction.
    Cai H, Erhardt P, Troppmair J, Diaz-Meco MT, Sithanandam G, Rapp UR, Moscat J, Cooper GM.
    Mol Cell Biol; 1993 Dec; 13(12):7645-51. PubMed ID: 8246981
    [Abstract] [Full Text] [Related]

  • 22. Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase.
    Bruder JT, Heidecker G, Rapp UR.
    Genes Dev; 1992 Apr; 6(4):545-56. PubMed ID: 1313769
    [Abstract] [Full Text] [Related]

  • 23. Characterization of recessive (mediator-) revertants from NIH 3T3 cells transformed with a c-H-ras oncogene.
    Yamada H, Omata-Yamada T, Lengyel P.
    J Biol Chem; 1991 Feb 25; 266(6):4002-9. PubMed ID: 1995648
    [Abstract] [Full Text] [Related]

  • 24. Analysis of a transformed cell line using antisense c-fos RNA.
    Mercola D, Westwick J, Rundell AY, Adamson ED, Edwards SA.
    Gene; 1988 Dec 10; 72(1-2):253-65. PubMed ID: 2468566
    [Abstract] [Full Text] [Related]

  • 25. Induction of transformation and DNA synthesis after microinjection of raf proteins.
    Smith MR, Heidecker G, Rapp UR, Kung HF.
    Mol Cell Biol; 1990 Jul 10; 10(7):3828-33. PubMed ID: 2192265
    [Abstract] [Full Text] [Related]

  • 26. Requirement for c-ras proteins during viral oncogene transformation.
    Smith MR, DeGudicibus SJ, Stacey DW.
    Nature; 1990 Jul 10; 320(6062):540-3. PubMed ID: 2938016
    [Abstract] [Full Text] [Related]

  • 27. Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells.
    Sklar MD, Thompson E, Welsh MJ, Liebert M, Harney J, Grossman HB, Smith M, Prochownik EV.
    Mol Cell Biol; 1991 Jul 10; 11(7):3699-710. PubMed ID: 2046673
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Regulating cell growth: casein-kinase-II-dependent phosphorylation of nuclear oncoproteins.
    Carroll D, Santoro N, Marshak DR.
    Cold Spring Harb Symp Quant Biol; 1988 Jul 10; 53 Pt 1():91-5. PubMed ID: 3076091
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Redox-Mediated Rewiring of Signalling Pathways: The Role of a Cellular Clock in Brain Health and Disease.
    Vujovic F, Shepherd CE, Witting PK, Hunter N, Farahani RM.
    Antioxidants (Basel); 2023 Oct 17; 12(10):. PubMed ID: 37891951
    [Abstract] [Full Text] [Related]

  • 36. Anti-proliferative effect of Annona extracts on breast cancer cells.
    Veisaga ML, Ahumada M, Soriano S, Acuna L, Zhang W, Leung I, Barnum R, Barbieri MA.
    Biocell; 2023 Aug 28; 47(8):1835-1852. PubMed ID: 37771344
    [Abstract] [Full Text] [Related]

  • 37. TRIM11 Posttranscriptionally Modulated by miR-5193 Facilitates Tumor Growth and Metastasis of Prostate Cancer.
    Pan Y, Yu H, Lu F.
    Technol Cancer Res Treat; 2023 Aug 28; 22():15330338231178639. PubMed ID: 37248611
    [Abstract] [Full Text] [Related]

  • 38. Multicenter Observational Study on Metastatic Non-Small Cell Lung Cancer Harboring BRAF Mutations: Focus on Clinical Characteristics and Treatment Outcome of V600E and Non-V600E Subgroups.
    Perrone F, Mazzaschi G, Minari R, Verzè M, Azzoni C, Bottarelli L, Nizzoli R, Pluchino M, Altimari A, Gruppioni E, Sperandi F, Andrini E, Guaitoli G, Bertolini F, Barbieri F, Bettelli S, Longo L, Pagano M, Bonelli C, Tagliavini E, Nicoli D, Ubiali A, Zangrandi A, Trubini S, Proietto M, Gnetti L, Tiseo M.
    Cancers (Basel); 2022 Apr 16; 14(8):. PubMed ID: 35454926
    [Abstract] [Full Text] [Related]

  • 39. Integrated molecular characterisation of the MAPK pathways in human cancers reveals pharmacologically vulnerable mutations and gene dependencies.
    Sinkala M, Nkhoma P, Mulder N, Martin DP.
    Commun Biol; 2021 Jan 04; 4(1):9. PubMed ID: 33398072
    [Abstract] [Full Text] [Related]

  • 40. The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy.
    Yuan J, Dong X, Yap J, Hu J.
    J Hematol Oncol; 2020 Aug 17; 13(1):113. PubMed ID: 32807225
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.